Previous studies have identified significant genetic, phenotypic, and functional dysregulation of TRPM3 in the NK cells of ME/CFS patients relative to matched HCs [19,20,21,23,24,25,28,45]. This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.